Related Experiment Videos
Successful aortic valve replacement in osteogenesis imperfecta: with special emphasis on peri-operative management
Insights
Osteogenesis imperfecta, a connective tissue disease, often affects the aortic valve. This case study details successful aortic valve replacement and hematologic management in a patient with type I osteogenesis imperfecta, addressing bleeding complications.
Area of Science:
- Cardiology
- Connective Tissue Diseases
- Hematology
Background:
- Valvular heart disease is a known complication of connective tissue diseases.
- Osteogenesis imperfecta (OI) frequently involves the aortic valve, necessitating surgical intervention.
- Aortic valve replacement in OI patients can be complicated by bleeding due to platelet dysfunction and capillary fragility.
Observation:
- A patient with type I osteogenesis imperfecta presented with aortic valve disease requiring replacement.
- The patient experienced significant bleeding complications post-operatively, linked to underlying hematologic issues.
Findings:
- Successful aortic valve replacement was achieved in the patient with type I osteogenesis imperfecta.
- Specific hematologic manipulations were critical in controlling post-operative bleeding.
- Effective management of platelet dysfunction and capillary fragility is key for surgical success.
Implications:
- This case highlights the importance of comprehensive pre-operative assessment and tailored hematologic management in OI patients undergoing cardiac surgery.
- It provides a model for managing bleeding complications in similar high-risk patients.
- Improved understanding of OI-associated bleeding risks can lead to better surgical outcomes and patient care.
Abstract:
Valvular heart disease is a recognized feature of the connective tissue diseases. It occurs to a variable extent in osteogenesis imperfecta and frequently involves the aortic valve. Replacement of the aortic valve, although required, may be complicated by bleeding problems secondary to platelet dysfunction and capillary fragility. A successful aortic valve replacement in a patient with type I osteogenesis imperfecta is described with special reference to hematologic manipulations to control bleeding post-operatively.